Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
Rx Only Prescribing Information
Medication labelWhy this: Advisory · dailymed-prescription
Entacapone tablets are indicated as an adjunct to levodopa and carbidopa to treat end-of-dose “wearing-off” in patients with Parkinson’s disease (see CLINICAL PHARMACOLOGY, Clinical Studies). Entacapone tablets effectiveness has not been systematically evaluated in patients with Parkinson’s disease who do not experience end-of-dose “wearing-off”.
- generic_name
- entacapone
- product_names
- Entacapone
- ndc
- 0615-8298, 33342-260, 0615-8298-39
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en